Literature DB >> 16619032

An aging pathway controls the TrkA to p75NTR receptor switch and amyloid beta-peptide generation.

Claudio Costantini1, Heidi Scrable, Luigi Puglielli.   

Abstract

Aging of the brain is characterized by marked changes in the expression levels of the neurotrophin receptors, TrkA and p75(NTR). An expression pattern in which TrkA predominates in younger animals switches to one in which p75(NTR) predominates in older animals. This TrkA-to-p75(NTR) switch is accompanied by activation of the second messenger ceramide, stabilization of beta-site amyloid precursor protein-cleaving enzyme-1 (BACE1), and increased production of amyloid beta-peptide (Abeta). Here, we show that the insulin-like growth factor-1 receptor (IGF1-R), the common regulator of lifespan and age-related events in many different organisms, is responsible for the TrkA-to-p75(NTR) switch in both human neuroblastoma cell lines and primary neurons from mouse brain. The signaling pathway that controls the level of TrkA and p75(NTR) downstream of the IGF1-R requires IRS2, PIP3/Akt, and is under the control of PTEN and p44, the short isoform of p53. We also show that hyperactivation of IGF1-R signaling in p44 transgenic animals, which show an accelerated form of aging, is characterized by early TrkA-to-p75(NTR) switch and increased production of Abeta in the brain.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16619032      PMCID: PMC1456930          DOI: 10.1038/sj.emboj.7601062

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  36 in total

1.  Insulin-like growth factor-1 and insulin mediate transient site-selective increases in tau phosphorylation in primary cortical neurons.

Authors:  M Lesort; G V Johnson
Journal:  Neuroscience       Date:  2000       Impact factor: 3.590

2.  Insulin and Alzheimer's disease: an amyloid connection.

Authors:  Douglas Galasko
Journal:  Neurology       Date:  2003-06-24       Impact factor: 9.910

3.  Proteolytic processing of the p75 neurotrophin receptor and two homologs generates C-terminal fragments with signaling capability.

Authors:  Kevin C Kanning; Mark Hudson; Paul S Amieux; Jesse C Wiley; Mark Bothwell; Leslayann C Schecterson
Journal:  J Neurosci       Date:  2003-07-02       Impact factor: 6.167

Review 4.  The role of insulin and insulin-like growth factor I in the molecular and cellular mechanisms underlying the pathology of Alzheimer's disease.

Authors:  Eva Carro; Ignacio Torres-Aleman
Journal:  Eur J Pharmacol       Date:  2004-04-19       Impact factor: 4.432

5.  A TrkA-to-p75NTR molecular switch activates amyloid beta-peptide generation during aging.

Authors:  Claudio Costantini; Richard Weindruch; Giuliano Della Valle; Luigi Puglielli
Journal:  Biochem J       Date:  2005-10-01       Impact factor: 3.857

6.  Blockade of the insulin-like growth factor I receptor in the choroid plexus originates Alzheimer's-like neuropathology in rodents: new cues into the human disease?

Authors:  Eva Carro; Jose Luis Trejo; Carlos Spuch; Delphine Bohl; Jean Michel Heard; Ignacio Torres-Aleman
Journal:  Neurobiol Aging       Date:  2005-11-07       Impact factor: 4.673

7.  Insulin-like growth factor I stimulates motility in human neuroblastoma cells.

Authors:  G E Meyer; E Shelden; B Kim; E L Feldman
Journal:  Oncogene       Date:  2001-11-08       Impact factor: 9.867

Review 8.  Evolutionary medicine: from dwarf model systems to healthy centenarians?

Authors:  Valter D Longo; Caleb E Finch
Journal:  Science       Date:  2003-02-28       Impact factor: 47.728

9.  Inhibitors of phosphoinositide 3-kinase, LY294002 and wortmannin, affect sperm capacitation and associated phosphorylation of proteins differently: Ca2+-dependent divergences.

Authors:  Veronica Nauc; Eve De Lamirande; Pierre Leclerc; Claude Gagnon
Journal:  J Androl       Date:  2004 Jul-Aug

10.  Insulin-like growth factor-I signaling in human neuroblastoma cells.

Authors:  Bhumsoo Kim; Cynthia M van Golen; Eva L Feldman
Journal:  Oncogene       Date:  2004-01-08       Impact factor: 9.867

View more
  52 in total

1.  Improved proteostasis in the secretory pathway rescues Alzheimer's disease in the mouse.

Authors:  Yajing Peng; Mi Jin Kim; Rikki Hullinger; Kenneth J O'Riordan; Corinna Burger; Mariana Pehar; Luigi Puglielli
Journal:  Brain       Date:  2016-01-19       Impact factor: 13.501

Review 2.  Aging of the brain, neurotrophin signaling, and Alzheimer's disease: is IGF1-R the common culprit?

Authors:  Luigi Puglielli
Journal:  Neurobiol Aging       Date:  2007-02-20       Impact factor: 4.673

3.  Expression of Trk A and Src and their interaction with ERβ ligand binding domain show age and sex dependent alteration in mouse brain.

Authors:  M K Thakur; V Paramanik
Journal:  Neurochem Res       Date:  2011-10-20       Impact factor: 3.996

Review 4.  Cellular Trafficking of Amyloid Precursor Protein in Amyloidogenesis Physiological and Pathological Significance.

Authors:  Noralyn Basco Mañucat-Tan; Khalil Saadipour; Yan-Jiang Wang; Larisa Bobrovskaya; Xin-Fu Zhou
Journal:  Mol Neurobiol       Date:  2018-05-24       Impact factor: 5.590

5.  Diminished trkA receptor signaling reveals cholinergic-attentional vulnerability of aging.

Authors:  Vinay Parikh; William M Howe; Ryan M Welchko; Sean X Naughton; Drew E D'Amore; Daniel H Han; Monika Deo; David L Turner; Martin Sarter
Journal:  Eur J Neurosci       Date:  2012-12-11       Impact factor: 3.386

6.  PCSK9 is required for the disposal of non-acetylated intermediates of the nascent membrane protein BACE1.

Authors:  Mary Cabell Jonas; Claudio Costantini; Luigi Puglielli
Journal:  EMBO Rep       Date:  2008-07-25       Impact factor: 8.807

7.  Apoptosis and in vitro Alzheimer disease neuronal models.

Authors:  P Calissano; C Matrone; G Amadoro
Journal:  Commun Integr Biol       Date:  2009

8.  Ceramide signaling in cancer and stem cells.

Authors:  Erhard Bieberich
Journal:  Future Lipidol       Date:  2008-06

9.  Altered longevity-assurance activity of p53:p44 in the mouse causes memory loss, neurodegeneration and premature death.

Authors:  Mariana Pehar; Kenneth J O'Riordan; Melissa Burns-Cusato; Matthew E Andrzejewski; Carlos Gil del Alcazar; Corinna Burger; Heidi Scrable; Luigi Puglielli
Journal:  Aging Cell       Date:  2010-04       Impact factor: 9.304

10.  Viable mouse gene ablations that robustly alter brain Aβ levels are rare.

Authors:  Jeremy H Toyn; Xu-Alan Lin; Mark W Thompson; Valerie Guss; Jere E Meredith; Sethu Sankaranarayanan; Nestor Barrezueta; John Corradi; Antara Majumdar; Daniel L Small; Melissa Hansard; Thomas Lanthorn; Ryan S Westphal; Charles F Albright
Journal:  BMC Neurosci       Date:  2010-11-05       Impact factor: 3.288

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.